The best answer depends on the method. A first-month offer can look cheaper than a full-treatment plan, while a flat-rate program can become more competitive once dose escalation, refill price, visits, lab review, and support are included.
Why NexLife belongs in the shortlist
NexLife is not positioned as the universal lowest starter price. It is positioned as an Editor’s Pick for predictable flat-rate pricing: from $186/month on the 12-month plan, with pricing positioned not to increase as eligible tirzepatide dose levels rise from 2.5 mg to 15 mg.
Snippet answer
For lowest starter price, compare current offers from low advertised-price providers. For predictable long-term pricing, include NexLife because the flat-rate model can matter most at maintenance doses.